Skip to content

Internet-delivered CBT for Adolescents With GAD

Internet-delivered Cognitive Behavioral Therapy for Adolescents With Generalized Anxiety Disorder - a Multiple Baseline Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03469453
Acronym
BIPWorry
Enrollment
13
Registered
2018-03-19
Start date
2017-11-28
Completion date
2018-08-28
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Keywords

GAD, Adolescents, Internet-delivered Cognitive behavioral therapy, ICBT, CBT

Brief summary

This multiple baseline evaluation aims to test the feasibility and preliminary effectiveness of Internet-delivered cognitive behavioral therapy (ICBT) for adolescents with Generalized Anxiety Disorder (GAD).

Detailed description

This pilot study aims to test Internet-delivered Cognitive Behavioral Therapy (ICBT) for adolescents with Generalized Anxiety Disorder (GAD) The study has a single case research design (multiple baseline) and will include 12 participants with GAD according to a semi structured diagnostic interview. Participants will be randomized to either two, six or ten weeks baseline measurements prior to starting treatment, and will thus work as their own controls. Primary outcome measures will be collected at 10 weeks after treatment start. Follow-up assessments will be made three month after treatment.

Interventions

Therapist-supported CBT delivered online.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* A score on the Penn State Worry Questionnaire for Children (PSWQ-C) of \> 30 * Fulfilling DSM-5 criteria for Generalized Anxiety Disorder * No other disorder or symptoms present in need of more urgent treatment * Aged between 13 and 17 years * Ability to read and write in Swedish * A parent or caregiver that is able to participate in the treatment * Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment * No other ongoing psychological treatment for any disorder

Exclusion criteria

* The presence of symptoms suggestive of a current diagnosis of Autistic Spectrum Disorder, Schizophrenia, Bipolar Disorder, Anorexia Nervosa, Bulimia, or Substance Use Disorder * Present risk of suicide * Present occurrence of domestic violence * Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)

Design outcomes

Primary

MeasureTime frameDescription
Brief Penn State Worry Questionnaire for Children10 weeks after baselineSelf-assessment of excessive worry for individual analysis in multiple baseline evaluation
Penn State Worry Questionnaire for Children10, 14 and 22 weeks after baselineChild and parent version, lower values indicating decrease in worry. Assessments used in group statistical analysis of clinical outcome

Secondary

MeasureTime frameDescription
Revised Children's Anxiety and Depression Scale10, 14 and 22 weeks after baselineChild and parent versions, lower values indicating decrease in anxiety and depression
Clinical Global Impression - Improvement10, 14 and 22 weeks after baselineClinician rated, higher values indicate larger improvement after treatment
Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual -IV10, 14 and 22 weeks after baselineDiagnostic interview
Clinician Severity Rating10, 14 and 22 weeks after baselineClinician rated severity with lower values indicating lower level of severity of a disorder
Children's Global Assessment Scale10, 14 and 22 weeks after baselineClinician rated global functioning, higher values indicate higher functioning
Brief Intolerance of Uncertainty Scale10, 14 and 22 weeks after baselineChild version, lower values indicating decrease in intolerance of uncertainty
Brief Cognitive Avoidance Questionnaire10, 14 and 22 weeks after baselineChild version, lower values indicating decrease in cognitive avoidance
Negative Problem Orientation Questionnaire, abbreviated10, 14 and 22 weeks after baselineChild version, lower values indicating decrease in negative problem orientation
Education, Work and Social Adjustment Scale10 and 22 weeks after baselineChild and parent versions, , lower values indicating decreased impairment due to worry

Other

MeasureTime frameDescription
Internet intervention Patient Adherence Scale5 and 10 weeks after baselineClinician rated, 5-item scale ranging from 0-4 with higher scores indicating higher participant adherence to treatment.
Treatment credibility and expectancy scale (child and parent version)10 weeks after baselineA 5-item scale, rated from 0-10, with higher scores indicating higher treatment credibility and expectancy.
Negative Events Questionnaire (child and parent version)10 weeks after baselineThe 5-item scale queries negative events during treatment and if the participants attributes the event to the intervention.
Client satisfaction questionnaire10 weeks after baselineChild- and parent rated treatment satisfaction is rated on an eight items scale,ange 0-3, with higher score indicating higher satisfaction..

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026